SEARCH

SEARCH BY CITATION

References

  • 1
    Rosenfield A, Maine D. Maternal mortality—a neglected tragedy. Where is the M in MCH? Lancet 1985;2(8446):8385 (July 13).
  • 2
    AbouZahr C, Wardlaw T. Maternal mortality at the end of a decade: signs of progress? Bull World Health Organ 2001;79(6):561568.
  • 3
    Liljestrand J, Pathmanathan I. Reducing maternal mortality: can we derive policy guidance from developing country experiences? J Public Health Policy 2004;25(3–4):299314.
  • 4
    Bartlett LA, Mawji S, Whitehead S, et al. Where giving birth is a forecast of death: maternal mortality in four districts of Afghanistan, 1999–2002. Lancet 2005;365(9462):864870 (March 2).
  • 5
    Le Coeur S, Khlat M, Halembokaka G, et al. HIV and the magnitude of pregnancy-related mortality in Pointe Noire, Congo. AIDS 2005;19(1):6975 (January 3).
  • 6
    Buttiens H, Marchal B, De Brouwere V. Skilled attendance at childbirth: let us go beyond the rhetorics. Trop Med Int Health 2004;9(6):653654 (June 9).
  • 7
    Tsu VD, Free MJ. Using technology to reduce maternal mortality in low-resource settings: challenges and opportunities. J Am Med Women's Assoc 2002;57(3):149153.
  • 8
    TsuVD, editor. New and underutilized technologies to reduce maternal mortality: papers from a 2003 Bellagio workshop. Int J Gynecol Obstet 2005;85(Suppl 1):S1S93.
  • 9
    Tsu VD, Shane B. New and underutilized technologies to reduce maternal mortality: call to action from a Bellagio workshop. Int J Gynecol Obstet 2004;85(Suppl 1):S83S93 (June).
  • 10
    Van den Broek N, Kulier R, Gulmezoglu AM, Villar J. Vitamin A supplementation during pregnancy. Cochrane Database Syst Rev 2002;(4):CD001996.
  • 11
    West Jr KP, Katz J, Khatry SK, et al. Double blind, cluster randomised trial of low dose supplementation with vitamin A or beta carotene on mortality related to pregnancy in Nepal. The NNIPS-2 Study Group. BMJ 1999;318(7183):570575 (February 27).
  • 12
    Bhutta ZA, Jackson AA, Lumbiganon PE. Nutrition as a preventative strategy against adverse pregnancy outcomes. J Nutr 2003;133(5 Suppl 2):1589S1767S (May).
  • 13
    Villar J, Merialdi M, Gulmezoglu AM, et al. Nutritional interventions during pregnancy for the prevention or treatment of maternal morbidity and preterm delivery: an overview of randomized controlled trials. J Nutr 2003;133(5 Suppl 2):1606S1625S (May).
  • 14
    West Jr KP. Vitamin A deficiency as a preventable cause of maternal mortality in undernourished societies: plausibility and next steps. Int J Gynecol Obstet 2004;85(Suppl 1):S24S27 (June).
  • 15
    Krasovec K. Auxiliary technologies related to transport and communication for obstetric emergencies. Int J Gynecol Obstet 2004;85(Suppl 1):S14S23 (June).
  • 16
    Tsu VD, Langer A, Aldrich T. Postpartum hemorrhage in developing countries: is the public health community using the right tools? Int J Gynecol Obstet 2004;85(Suppl 1):S42S51 (June).
  • 17
    International joint policy statement. FIGO/ICM global initiative to prevent post-partum hemorrhage. J Obstet Gynaecol Can 2004;26(12):11001111 (December).
  • 18
    Elbourne DR, Prendiville WJ, Carroli G, Wood J, McDonald S. Prophylactic use of oxytocin in the third stage of labour. Cochrane Database Syst Rev 2001;(4):CD001808.
  • 19
    Tsu VD, Sutanto A, Vaidya K, Coffey P, Widjaya A. Oxytocin in prefilled Uniject injection devices for managing third-stage labor in Indonesia. Int J Gynecol Obstet 2003;83(1):103111 (October).
  • 20
    Gulmezoglu AM, Villar J, Ngoc NT, et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 2001;358(9283):689695 (September 1).
  • 21
    Gulmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for prevention of postpartum haemorrhage. Cochrane Database Syst Rev 2004;(1):CD000494.
  • 22
    Walraven G, Blum J, Dampha Y, et al. Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial. BJOG 2005;112. DOI: 10.1111/j.1471-0528.2005.00711.x. In press.
  • 23
    Wright JM, Newton W. Is rectal misoprostol as effective as oxytocin in preventing postpartum hemorrhage? J Fam Pract 2003;52(4):281282 (April).
  • 24
    Karkanis SG, Caloia D, Salenieks ME, et al. Randomized controlled trial of rectal misoprostol versus oxytocin in third stage management. J Obstet Gynaecol Can 2002;24(2):149154 (February).
  • 25
    Brees C, Hensleigh PA, Miller S, Pelligra R. A non-inflatable anti-shock garment for obstetric hemorrhage. Int J Gynecol Obstet 2004;87(2):119124 (November).
  • 26
    Mousa HA, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev 2003;(1):CD003249.
  • 27
    Carroli G, Bergel E. Umbilical vein injection for management of retained placenta. Cochrane Database Syst Rev 2001;(4):CD001337.
  • 28
    Akhter S, Begum MR, Kabir Z, Rashid M, Laila TR, Zabeen F. Use of a condom to control massive postpartum hemorrhage. Med Gen Med 2003;5(3):38 (September 11).
  • 29
    World Health Organization. The World Health Report 2005: Make Every Mother and Child Count. Geneva: WHO, 2005.
  • 30
    Hugonnet S, Pittet D. Hand hygiene revisited: lessons from the past and present. Curr Infect Dis Rep 2000;2(6):484489 (December).
  • 31
    Taha TE, Biggar RJ, Broadhead RL, et al. Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial. BMJ 1997;315(7102):216219 (July 26).
  • 32
    Hussein J, Fortney JA. Puerperal sepsis and maternal mortality: what role can new technologies play? Int J Gynecol Obstet 2004;85(Suppl 1):S52S61 (June).
  • 33
    AbouZahr C. Global burden of maternal death and disability. Br Med Bull 2003;67: 111.
  • 34
    Rogo K. Improving technologies to reduce abortion-related morbidity and mortality. Int J Gynecol Obstet 2004;85(Suppl 1):S73S82 (June).
  • 35
    World Health Organization. Safe Abortion: Technical and Policy Guidance for Health Systems. Geneva: WHO, 2003.
  • 36
    Blanchard K, Winikoff B, Coyaji K, Nguyen TN. Misoprostol alone—a new method of medical abortion? J Am Med Women's Assoc 2000;55(Suppl 3):189190.
  • 37
    Villar J, Say L, Gulmezoglu AM, et al. Eclampsia and pre-eclampsia: a worldwide health problem since 2000 years. In: CritchleyHOD, PostonL, WalkerJ, editors. Pre-eclampsia. London: RCOG Press, 2003: 189207.
  • 38
    Villar J, Say L, Shennan A, et al. Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of pre-eclampsia and eclampsia. Int J Gynecol Obstet 2004;85 (Suppl 1):S28S41 (June).
  • 39
    Duley L, Henderson-Smart DJ, Knight M, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2004;(1):CD004659.
  • 40
    Waugh JJ, Bell SC, Kilby MD, et al. Optimal bedside urinalysis for the detection of proteinuria in hypertensive pregnancy: a study of diagnostic accuracy. BJOG 2005;112(4):412417 (April).
  • 41
    Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 2004;104(6):13671391 (December).
  • 42
    Duley L, Gulmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2003;(2):CD000025.
  • 43
    Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365(9461):785799 (February 26).
  • 44
    Hofmeyr GJ. Obstructed labor: using better technologies to reduce mortality. Int J Gynecol Obstet 2004;(85 Suppl 1):S62S72 (June).
  • 45
    Lavender T, Alfirevic Z, Walkinshaw S. Partogram action line study: a randomised trial. Br J Obstet Gynaecol 1998;105(9):976980 (September).
  • 46
    Pattinson RC, Howarth GR, Mdluli W, Macdonald AP, Makin JD, Funk M. Aggressive or expectant management of labour: a randomised clinical trial. Br J Obstet Gynaecol 2003;110(5):457461 (May).
  • 47
    O'Grady JP, Pope CS, Patel SS. Vacuum extraction in modern obstetric practice: a review and critique. Curr Opin Obstet Gynecol 2000;12(6):475480 (December).
  • 48
    Vacca A. Operative vaginal delivery: clinical appraisal of a new vacuum extraction device. Aust N Z J Obstet Gynaecol 2001;41(2):156160 (May).
  • 49
    Wykes CB, Johnston TA, Paterson-Brown S, Johanson RB. Symphysiotomy: a lifesaving procedure. BJOG 2003;110(2):219221 (February).
  • 50
    Bjorklund K. Minimally invasive surgery for obstructed labour: a review of symphysiotomy during the twentieth century (including 5000 cases). BJOG 2002;109(3):236248 (March).
  • 51
    Free MJ. Achieving appropriate design and widespread use of health care technologies in the developing world. Overcoming obstacles that impede the adaptation and diffusion of priority technologies for primary health care. Int J Gynecol Obstet 2004;85(Suppl 1):S3S13 (June).
  • 52
    DaveyE, editor. The 10/90 Report on Health Research 2003–2004. Geneva: Global Forum for Health Research, 2004: 3546.
  • 53
    Tsu VD. New and underused technologies to reduce maternal mortality. Lancet 2004;363(9402):7576 (January 3).